President, White Arrow Consulting, LLC

Dr. Schreiber joined Roche Diagnostics (previously Boehringer Mannheim Germany) in 1986 and moved to the US in 1994.  He held several functions in R&D (analytics, process development) and Operations (quality system, purchasing), before he assumed responsibility for the diabetes care business unit R&D in the US organization in 1996.  In 2001 Dr.Schreiber accepted the position of VP R&D and Business Development for a newly created business,, wherein Roche Diagnostics built an internet-based medical practice.

After his retirement from Roche, Dr. Schreiber works as Business Development consultant and entrepreneur in the Life Sciences. He has founded and uses as his business platform White Arrow Consulting LLC ( From 2005 to 2007 he worked with Quadraspec Inc. as Chief Operating Officer. From 2007 to 2010, he worked with Physical Logic AG as VP R&D, CEO, and Director of its Diabetes Business Unit. After that, he served as CEO of Access Health Wealth and of the Indiana Biodefense Consortium, which he founded. Dr. Schreiber was the CEO of Indiana BioPharma LLC to build up a biotech Contract Development and Manufacturing Organization. In addition, he was advising Head of Business Development of MedeoLinx LLC.

In 2015, Dr. Schreiber founded The Executive Consortium, and since 2017 he has served as VP R&D of AgenDx Biosciences, commercializing a fast and affordable diagnostic test for pancreatic cancer.

Dr. Schreiber is a faculty member of IUPUI and Butler University in Indianapolis, Indiana, teaching in Engineering and Business.

Dr. Schreiber holds a Ph.D. in physics from Giessen University, Germany, specialized in biophysics and was a post doc at the National Institute for Environmental Health Sciences in Research Triangle Park, NC, USA.

Dr. Schreiber is a Board Member of the Ensemble Music Society of Indianapolis and is the Treasurer and Past President of the Board of Diversity & Innovation Institute.